TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · IEX Real-Time Price · USD
0.940
-0.010 (-1.07%)
At close: Jul 2, 2024, 4:00 PM
0.926
-0.014 (-1.48%)
After-hours: Jul 2, 2024, 6:41 PM EDT
TransCode Therapeutics Market Cap
TransCode Therapeutics has a market cap or net worth of $6.18 million as of July 2, 2024. Its market cap has increased by 180.72% in one year.
Market Cap
6.18M
Enterprise Value
1.60M
1-Year Change
180.72%
Ranking
Category
Stock Price
$0.94
Market Cap Chart
Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $6.18M, a decrease of -87.10%. That is a compound annual growth rate of -49.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 6.40M | 93.94% |
| Dec 29, 2023 | 3.30M | -62.07% |
| Dec 30, 2022 | 8.70M | -73.48% |
| Dec 31, 2021 | 32.80M | -31.48% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cyclerion Therapeutics | 6.30M |
| ENDRA Life Sciences | 6.27M |
| Telesis Bio | 6.25M |
| GT Biopharma | 6.21M |
| Tenax Therapeutics | 6.21M |
| Sunshine Biopharma | 6.07M |
| Genetic Technologies | 6.04M |
| FSD Pharma | 5.94M |